Rapt Therapeutics earnings were -$129.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest RAPT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$53.2M, up 188.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RAPT reported annual earnings of -$129.9M, with 11.2% growth. The next RAPT earnings date is May 7, 2025.
What were Rapt Therapeutics's earnings last quarter?
On RAPT's earnings call on Invalid Date, Rapt Therapeutics (NASDAQ: RAPT) reported Q4 2024 earnings per share (EPS) of -$1.22, up 50.62% year over year. Total RAPT earnings for the quarter were -$53.25 million. In the same quarter last year, Rapt Therapeutics's earnings per share (EPS) was -$0.81.
The next RAPT earnings call is Invalid Date. Add RAPT to your watchlist to be reminded of Rapt Therapeutics's next earnings date.
What was RAPT's earnings growth in the past year?
As of Rapt Therapeutics's earnings date in Invalid Date, Rapt Therapeutics's earnings has grown year over year. RAPT earnings in the past year totalled -$129.87 million.
Is Rapt Therapeutics profitable or losing money?
As of the last Rapt Therapeutics earnings report, Rapt Therapeutics is currently losing money. Rapt Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$129.87 million, a 11.19% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.